Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;115(4):804-11.
doi: 10.1097/ALN.0b013e31822e94bd.

Cysteinyl leukotrienes impair hypoxic pulmonary vasoconstriction in endotoxemic mice

Bodil Petersen  1 , K Frank Austen, Kenneth D Bloch, Yukako Hotta, Fumito Ichinose, Yoshihide Kanaoka, Warren M Zapol
Affiliations

Cysteinyl leukotrienes impair hypoxic pulmonary vasoconstriction in endotoxemic mice

Bodil Petersen et al. Anesthesiology. 2011 Oct.

Abstract

Background: Sepsis impairs hypoxic pulmonary vasoconstriction (HPV) in patients and animal models, contributing to systemic hypoxemia. Concentrations of cysteinyl leukotrienes are increased in the bronchoalveolar lavage fluid of patients with sepsis, but the contribution of cysteinyl leukotrienes to the impairment of HPV is unknown.

Methods: Wild-type mice, mice deficient in leukotriene C(4) synthase, the enzyme responsible for cysteinyl leukotriene synthesis, and mice deficient in cysteinyl leukotriene receptor 1 were studied 18 h after challenge with either saline or endotoxin. HPV was measured by the increase in left pulmonary vascular resistance induced by left mainstem bronchus occlusion. Concentrations of cysteinyl leukotrienes were determined in the bronchoalveolar lavage fluid.

Results: In the bronchoalveolar lavage fluid of all three strains, cysteinyl leukotrienes were not detectable after saline challenge; whereas endotoxin challenge increased cysteinyl leukotriene concentrations in wild-type mice and mice deficient in cysteinyl leukotriene receptor 1, but not in mice deficient in leukotriene C(4) synthase. HPV did not differ among the three mouse strains after saline challenge (120 ± 26, 114 ± 16, and 115 ± 24%, respectively; mean ± SD). Endotoxin challenge markedly impaired HPV in wild-type mice (41 ± 20%) but only marginally in mice deficient in leukotriene C(4) synthase (96 ± 16%, P < 0.05 vs. wild-type mice), thereby preserving systemic oxygenation. Although endotoxin modestly decreased HPV in mice deficient in cysteinyl leukotriene receptor 1 (80 ± 29%, P < 0.05 vs. saline challenge), the magnitude of impairment was markedly less than in endotoxin-challenged wild-type mice.

Conclusion: Cysteinyl leukotrienes importantly contribute to endotoxin-induced impairment of HPV in part via a cysteinyl leukotriene receptor 1-dependent mechanism.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Occlusion of the left mainstem bronchus-induced increase of left pulmonary vascular resistance in WT, LTC4S-/-, and CysLT1-/- mice at 18 hours after challenge with either saline or lipopolysaccharide (n=9 in each group). (B) Values of oxygen in the arterial blood during occlusion of the left mainstem bronchus at the end of the HPV measurements. *P<0.05 differs vs. saline-challenged mice of the respective genotype, # P<0.05 differs vs. lipopolysaccharide-challenged WT mice, § P<0.05 differs vs. lipopolysaccharide-challenged CysLT1-/- mice. CysLT1-/-, mice congenitally deficient in the cysteinyl leukotriene receptor 1; LPS, lipopolysaccharide; LPVR, left pulmonary vascular resistance; LTC4S-/-, mice congenitally deficient in leukotriene C4 synthase; mmHg, millimeters of mercury; PaO2, level of oxygen in the arterial blood; WT, wild type mice. All data mean ± SD.
Figure 2
Figure 2
(A) In WT (n=6), LTC4S-/-(n=6), and CysLT1-/- mice (n=7) the circulating leukocyte concentrations were markedly reduced after lipopolysaccharide challenge compared with WT (n=6), LTC4S-/- (n=7), and CysLT1-/- (n=6) mice after saline challenge. (B) Lung tissue myeloperoxidase activity was greater in lipopolysaccharide-treated WT (n=5), LTC4S-/- (n=7), and CysLT1-/- (n=7) mice than in saline-treated WT (n=6), LTC4S-/- (n=6), and CysLT1-/- (n=6) mice. Blood and tissue samples were taken 18 hours after lipopolysaccharide-challenge. *P<0.05 differs vs. saline-challenged mice of the respective genotype. CysLT1-/-, mice congenitally deficient in the cysteinyl leukotriene receptor 1; LPS, lipopolysaccharide; LTC4S-/-, mice congenitally deficient in leukotriene C4 synthase; MPO, myeloperoxidase; WBC, white blood cell count; WT, wild type mice. All data mean ± SD.
Figure 3
Figure 3
The concentration of LTB4 in bronchoalveolar lavage fluid did not differ between saline-challenged WT (n=4), LTC4S-/-(n=5), and CysLT1-/- (n=5) mice and lipopolysaccharide-challenged WT (n=6), LTC4S-/-(n=6), and CysLT1-/- (n=6) mice 18 hours after challenge. (B) In the same mice, levels of cysLTs (LTC4/D4/E4) in the bronchoalveolar lavage fluid were higher in WT and CysLT1-/- mice after lipopolysaccharide challenge than in saline-challenged WT and CysLT1-/- mice. As expected, no cysLTs were detectable in bronchoalveolar lavage fluid from the LTC4S-/- mice after challenge with either saline or lipopolysaccharide. * P<0.05 differs vs. saline-challenged mice of the respective genotype, # P<0.05 differs vs. lipopolysaccharide-challenged WT mice, § P<0.05 differs vs. lipopolysaccharide-challenged CysLT1-/- mice. B4, cysteinyl leukotriene B4; C4/D4/E4, cysteinyl leukotriene C4/D4/E4; CysLT1-/-, mice congenitally deficient in the cysteinyl leukotriene receptor 1; LPS, lipopolysaccharide; LTC4S-/-, mice congenitally deficient in leukotriene C4 synthase; WT, wild type mice. The levels of LTB4 and cysLT are depicted as individual values with arithmetic means.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Thomas HM, 3rd, Garrett RC. Strength of hypoxic vasoconstriction determines shunt fraction in dogs with atelectasis. J Appl Physiol. 1982;53:44–51. - PubMed
    1. Brimioulle S, LeJeune P, Naeije R. Effects of hypoxic pulmonary vasoconstriction on pulmonary gas exchange. J Appl Physiol. 1996;81:1535–43. - PubMed
    1. Dantzker DR, Brook CJ, Dehart P, Lynch JP, Weg JG. Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis. 1979;120:1039–52. - PubMed
    1. Sharma S, Kumar A. Septic shock, multiple organ failure, and acute respiratory distress syndrome. Curr Opin Pulm Med. 2003;9:199–209. - PubMed
    1. Weir EK, Mlczoch J, Reeves JT, Grover RF. Endotoxin and prevention of hypoxic pulmonary vasoconstriction. J Lab Clin Med. 1976;88:975–83. - PubMed

Publication types

MeSH terms